NDC 61755-039

REGEN-COV

Casirivimab And Imdevimab

REGEN-COV is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Regeneron Pharmaceuticals, Inc.. The primary component is Casirivimab; Imdevimab.

• Product ID: 61755-039_1b115152-c792-4dbd-aede-52dc7fdf8436
• NDC: 61755-039
• Product Type: Human Prescription Drug
• Proprietary Name: REGEN-COV
• Generic Name: Casirivimab And Imdevimab
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-06-03
• Marketing Category: UNAPPROVED DRUG OTHER /
• Labeler Name: Regeneron Pharmaceuticals, Inc.
• Substance Name: CASIRIVIMAB; IMDEVIMAB
• Active Ingredient Strength: 600 mg/10mL; mg/10mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 61755-039-01

1 VIAL, GLASS in 1 CARTON (61755-039-01) > 10 mL in 1 VIAL, GLASS (61755-039-00)

• Marketing Start Date: 2021-06-03
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "REGEN-COV" or generic name "Casirivimab And Imdevimab"

NDC	Brand Name	Generic Name
61755-035	REGEN-COV	casirivimab and imdevimab
61755-036	REGEN-COV	casirivimab and imdevimab
61755-037	REGEN-COV	casirivimab and imdevimab
61755-038	REGEN-COV	casirivimab and imdevimab